Platelet interactions as therapeutic targets for prevention of atherothrombosis

被引：3

作者：

Smid, Jan ^{[2
]}

Braun-Dullaeus, Ruediger ^{[2
]}

Gawaz, Meinrad ^{[1
]}

Langer, Harald F. ^{[1
]}

机构：

[1] Eberhard Karls Univ Tuebingen, Kardiol, Med Klin 2, Otfried Muellerstr 10, D-72076 Tubingen, Germany

[2] Univ Klinikum Magdeburg, Univ Klin Kardiol Angiol & Pneumol, D-39120 Magdeburg, Germany

来源：

FUTURE CARDIOLOGY | 2009年 / 5卷 / 03期

关键词：

atherothrombosis; cell-cell interaction; inflammation; platelet; therapy;

D O I：

10.2217/FCA.09.9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Physiologically, platelets perform important tasks to maintain the homeostasis of the vascular wall and the surrounding environment. In pathologic conditions, however, platelets contribute to the formation of atherosclerotic plaques as well as to atherothrombotic events (i.e., acute myocardial infarction). This review aims to elucidate the role of platelets in atherogenesis and atherothrombosis and to provide an insight into current and future strategies for platelet inhibition.

引用

页码：285 / 296

页数：12

共 147 条

[41] Regulation of platelet functions by P2 receptors [J].

Gachet, C .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :277-300

[42] The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies [J].

Gaussem, P ;

Reny, JL ;

Thalamas, C ;

Chatelain, N ;

Kroumova, M ;

Jude, B ;

Boneu, B ;

Fiessinger, AN .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) :1437-1445

[43] Platelets in inflammation and atherogenesis [J].

Gawaz, M ;

Langer, H ;

May, AE .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (12) :3378-3384

[44] Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium [J].

Gawaz, M .

CARDIOVASCULAR RESEARCH, 2004, 61 (03) :498-511

[45] Vitronectin receptor (alpha(nu)beta(3)) mediates platelet adhesion to the luminal aspect of endothelial cells - Implications for reperfusion in acute myocardial infarction [J].

Gawaz, M ;

Neumann, FJ ;

Dickfeld, T ;

Reininger, A ;

Adelsberger, H ;

Gebhardt, A ;

Schomig, A .

CIRCULATION, 1997, 96 (06) :1809-1818

[46] Platelet function in acute myocardial infarction treated with direct angioplasty [J].

Gawaz, M ;

Neumann, FJ ;

Ott, I ;

Schiessler, A ;

Schomig, A .

CIRCULATION, 1996, 93 (02) :229-237

[47] Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism.: Implications for atherogenesis [J].

Gawaz, M ;

Brand, K ;

Dickfeld, T ;

Pogatsa-Murray, G ;

Page, S ;

Bogner, C ;

Koch, W ;

Schömig, A ;

Neumann, FJ .

ATHEROSCLEROSIS, 2000, 148 (01) :75-85

[48] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[49] First-in-human evaluation of anti-von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers [J].

Gilbert, James C. ;

DeFeo-Fraulini, Tia ;

Hutabarat, Renta M. ;

Horvath, Christopher J. ;

Merlino, Patricia G. ;

Marsh, H. Nicholas ;

Healy, Judith M. ;

BouFakhreddine, Sleiman ;

Holohan, Thomas V. ;

Schaub, Robert G. .

CIRCULATION, 2007, 116 (23) :2678-2686

[50] Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention:: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial [J].

Greenbaum, AB ;

Grines, CL ;

Bittl, JA ;

Becker, RC ;

Kereiakes, DJ ;

Gilchrist, IC ;

Clegg, J ;

Stankowski, JE ;

Grogan, DR ;

Harrington, RA ;

Emanuelsson, H ;

Weaver, WD .

AMERICAN HEART JOURNAL, 2006, 151 (03) :689.e1-689.e10

← 1 2 3 4 5 6 7 8 9 10 →